Notably, CD133+ CSCs in glioblastoma promote tumor angiogenesis by secreting pro-angiogenic factors such as VEGF and stromal-derived factor-1 (SDF-1), attracting EPCs to the tumor site [241]. The gene discussed is PROM1; the disease is neoplasm.